Cardinal Health (CAH) reported $57.45 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 11.6%. EPS of $1.82 for the same period compares to $1.32 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $56.82 billion, representing a surprise of +1.10%. The company delivered an EPS surprise of +16.67%, with the consensus EPS estimate being $1.56.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...

Shares of Cardinal Health (CAH) have been strong performers lately, with the stock up 4.3% over the past month. The stock hit a new 52-week high of $111.4 in the previous session. Cardinal Health has gained 8.3% since the start of the year compared to the 2.7% move for the Zacks Medical sector and the 1.9% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus est ...

Cardinal Health (CAH) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $1.40 per share when it actually produced earnings of $1.73, delivering a surprise of 23.57%.Over the last four q ...

Q2 FY24 Earnings Cardinal Health, Inc. February 1, 2024 ...

Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased 38% to $1.82 Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35, from $6.75 to $7.002,3 Fiscal 2024 non-GAAP adjusted free cash flow guidance raised to ~$2.5 billion, from ~$2.0 billion Cardinal Health to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enh ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Cardinal Health (CAH) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Cardinal Health is a member of our Medical group, which includes 1074 different companies and currently sits at #9 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different ...

Cardinal Health Inc. CAH, +0.73% announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash. Cardinal said the acquisition expands its offering in therapeutic areas by boosting its analytics capabilities and service offerings, and increases its data and research opportunities with biopharmaceutical manufacturers. Specialty Networks’ PPS Analytics analyzes data, from sources including electronic medical records, imaging and dispensing systems and uses artificial intelligence to prov ...

Cardinal Health, Inc. (CAH) is scheduled to report second-quarter fiscal 2024 results on Feb 1, before the opening bell.In the last reported quarter, the company delivered an earnings surprise of 23.57%. CAH’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 15.67%.Q2 EstimatesFor the fiscal second quarter, the consensus mark for earnings is pegged at $1.57 per share, indicating an improvement of 18.9% from the prior-year quarter’s reported ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond ...